Control Bionics (ASX:CBL) share price doubles after successful IPO

The Control Bionics Limited (ASX:CBL) share price is rocketing higher after completing its IPO this morning…

A medical researcher works on a bichip, indicating share price movement in ASX tech companies

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Control Bionics Limited (ASX: CBL) share price landed on the ASX boards this morning following the successful completion of its initial public offering (IPO). And what a start it has had!

At the time of writing, the medical technology company's shares are fetching $1.21.

This is more than double the Control Bionics listing price of 60 cents.

What is Control Bionics?

Control Bionics is a medical technology company founded by former CNN anchor, Peter Ford.

Whilst working at CNN, Mr Ford taught himself to code and, inspired by Stephen Hawking, began developing software that would allow severely disabled people to operate and communicate using only their thoughts and neural signals.

The company notes that this technology is making a huge difference to the lives of those using it.

Furthermore, it has now gone well beyond basic communication and can allow those with diseases such as motor neurone disease (MND) to do things that haven't been possible for a long time. This includes gaming, controlling a television, and continuing with careers.

An example of the latter is Professor Justin Yerbury, who was recognised in this year's Australia Day honours list for his outstanding contribution to research regarding MND.

Using Control Bionic's NeuroNode system, Mr Yerbury has been able to continue teaching and researching in his field of Neurodegenerative Diseases at Wollongong University.

In FY 2020, the company generated $3.1 million in product revenue, which represented growth of 297% on FY 2019. And despite challenges presented by COVID-19, it has achieved unaudited revenue growth of approximately 41% in the first quarter compared to the prior corresponding period.

The Control Bionics IPO.

Control Bionics' IPO raised a total of $15 million at $0.60 per new share. This gave the company a $50 million market cap.

Management revealed that demand was so strong for its IPO that it was restricted to priority offer applications only after just a week.

Speaking about the offering, Chairman Roger Hawke commented: "The funds raised by this Offer will provide Control Bionics with working capital to execute our growth strategy in North America, increase our presence in Australia and prepare for entry to other priority markets including Japan. Additionally, funds will be used to support the marketing for existing products and to fund continued development of the hardware and software for a range of new, advanced applications."

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of CBL Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX shares finished the trading week on a high this Friday.

Read more »

A businessman stacks building blocks.
Technology Shares

6% gain! What's up with Block shares today?

Block shares are up more than 34% since 2 May.

Read more »

Broker looking at the share price.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

Why ARB, Block, Mayne Pharma, and Paladin Energy shares are charging higher today

These shares are having a strong finish to the week. But why?

Read more »

A woman puts her hands up as she smashes and breaks through a glass ceiling.
Share Gainers

How these 5 ASX 200 stocks are smashing the benchmark this week

These fives ASX 200 stocks have made some very happy shareholders this week. Here’s how.

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Catalyst Metals, Duratec, Nufarm, and Rio Tinto shares are dropping today

These shares are ending the week in the red. But why?

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

After its strategy day, what does Macquarie think Wesfarmers shares are worth?

Let's see what the broker is saying about this blue chip.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Technology Shares

After surging 13% yesterday, are TechnologyOne shares a buy, hold or sell according to Macquarie?

Valuations matter when investing, and Macquarie feels no different.

Read more »